JP2013520167A5 - - Google Patents

Download PDF

Info

Publication number
JP2013520167A5
JP2013520167A5 JP2012553903A JP2012553903A JP2013520167A5 JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5 JP 2012553903 A JP2012553903 A JP 2012553903A JP 2012553903 A JP2012553903 A JP 2012553903A JP 2013520167 A5 JP2013520167 A5 JP 2013520167A5
Authority
JP
Japan
Prior art keywords
subject
pharmaceutical composition
immune response
administration
influenza
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012553903A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013520167A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/000300 external-priority patent/WO2011102900A1/en
Publication of JP2013520167A publication Critical patent/JP2013520167A/ja
Publication of JP2013520167A5 publication Critical patent/JP2013520167A5/ja
Pending legal-status Critical Current

Links

JP2012553903A 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン Pending JP2013520167A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US30575910P 2010-02-18 2010-02-18
US30576810P 2010-02-18 2010-02-18
US61/305,768 2010-02-18
US61/305,759 2010-02-18
PCT/US2011/000300 WO2011102900A1 (en) 2010-02-18 2011-02-18 Universal virus-like particle (vlp) influenza vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2016131988A Division JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Publications (2)

Publication Number Publication Date
JP2013520167A JP2013520167A (ja) 2013-06-06
JP2013520167A5 true JP2013520167A5 (enExample) 2014-04-03

Family

ID=44483229

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012553903A Pending JP2013520167A (ja) 2010-02-18 2011-02-18 万能ウイルス様粒子(vlp)インフルエンザワクチン
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2016131988A Expired - Fee Related JP6524555B2 (ja) 2010-02-18 2016-07-01 万能ウイルス様粒子(vlp)インフルエンザワクチン

Country Status (6)

Country Link
US (4) US9352031B2 (enExample)
EP (1) EP2536428B1 (enExample)
JP (2) JP2013520167A (enExample)
CN (1) CN102858368B (enExample)
CA (1) CA2789945A1 (enExample)
WO (1) WO2011102900A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
DK2610345T3 (en) 2007-11-27 2015-12-07 Medicago Inc RECOMBINANT INFLUENZA VIRUS SIMULAR PARTICULARS (VLPS) MADE IN TRANSGENE PLANTS THAT EXPRESS HEMAGGLUTININ
JP2013520167A (ja) * 2010-02-18 2013-06-06 テクノヴァックス,インコーポレイテッド 万能ウイルス様粒子(vlp)インフルエンザワクチン
CN103154021A (zh) * 2010-08-16 2013-06-12 威斯特解剖及生物研究所 通用甲型流感疫苗
WO2013044203A2 (en) * 2011-09-23 2013-03-28 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPTARTMENT OF HEALTH & HUMAN SERVICES Novel influenza hemagglutinin protein-based vaccines
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CN103930435A (zh) * 2011-09-30 2014-07-16 麦迪卡格公司 增加植物中病毒样颗粒的产率
US20140302124A1 (en) * 2011-10-19 2014-10-09 Immunotape, Inc. Cytotoxic T Lymphocyte Inducing Immunogens For Prevention Treatment and Diagnosis of INFLUENZA VIRUS INFECTION
ES2657875T3 (es) 2012-03-22 2018-03-07 Fraunhofer Usa Inc. Partículas tipo virus que comprenden una proteína de la matriz de un virus encapsulado de plantas y usos de las mismas
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
IL241692B2 (en) 2013-03-28 2023-12-01 Medicago Inc Influenza virus-like particle production in plants
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
ES2837392T3 (es) * 2013-10-02 2021-06-30 Medimmune Llc Anticuerpos anti-influenza A neutralizantes y usos de los mismos
CN105792842B (zh) 2013-10-11 2020-06-02 美利坚合众国, 由健康及人类服务部部长代表 埃巴病毒疫苗
WO2015101666A1 (en) 2014-01-03 2015-07-09 Fundación Biofísica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
EP3157557A1 (en) * 2014-06-20 2017-04-26 The U.S.A. as represented by the Secretary, Department of Health and Human Services Polyvalent influenza virus-like particles (vlps) and use as vaccines
KR102713707B1 (ko) 2014-12-31 2024-10-04 더 유나이티드 스테이츠 오브 어메리카, 애즈 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 신규 다가 나노입자 기반 백신
US11324816B2 (en) 2015-08-31 2022-05-10 Technovax, Inc. Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine
IL303650B2 (en) 2016-09-02 2025-02-01 Us Health Stable group 2 trimers from the stem region of influenza hemagglutinin and their uses
MX2023012554A (es) * 2018-12-12 2023-11-08 Cambridge Tech Llc Vacuna universal contra la gripe.
CN110272473B (zh) * 2019-07-10 2021-03-02 军事科学院军事医学研究院军事兽医研究所 甲型流感通用型病毒样颗粒及其制备方法和应用
US20230321219A1 (en) * 2020-08-17 2023-10-12 Technovax, Inc. SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS [SARS-CoV-2]-VIRUS-LIKE PARTICLE [VLP] VACCINE: COMPOSITIONS, DELIVERY STRATEGIES, METHODS AND USES
WO2022061264A1 (en) * 2020-09-21 2022-03-24 University Of Georgia Research Foundation, Inc. Piv5-based covid-19 vaccine
CN112342149A (zh) * 2020-11-12 2021-02-09 新疆畜牧科学院兽医研究所(新疆畜牧科学院动物临床医学研究中心) 一种禽流感病毒样颗粒组装表达系统及其应用
EP4456915A1 (en) * 2021-12-31 2024-11-06 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
CN120053630B (zh) * 2025-04-28 2025-07-18 中国医学科学院医学生物学研究所 一种广谱流感疫苗的抗原表位肽组合及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1196788C (zh) * 2000-06-23 2005-04-13 惠氏控股有限公司 野生型和嵌合流感病毒样颗粒(vlp)的装配
US8592197B2 (en) * 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
US8080255B2 (en) * 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
US20060051859A1 (en) * 2004-09-09 2006-03-09 Yan Fu Long acting human interferon analogs
CA2615658A1 (en) * 2005-07-19 2007-01-25 Dow Global Technolgies Inc. Recombinant flu vaccines
TWI488968B (zh) * 2005-10-18 2015-06-21 Novavax Inc 功能性流行性感冒類病毒顆粒(VLPs)
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
US9101578B2 (en) 2006-05-01 2015-08-11 Technovax, Inc. Polyvalent influenza virus-like particle (VLP) compositions
CA2657955A1 (en) * 2006-07-27 2008-08-07 Ligocyte Pharmaceuticals, Inc. Chimeric virus-like particles
WO2008061243A2 (en) 2006-11-16 2008-05-22 Novavax, Inc. Respiratory syncytial virus-virus like particle (vlps)
EP2364167B1 (en) * 2008-11-25 2016-08-17 Nanotherapeutics, Inc. Method for production of ph stable enveloped viruses
WO2010117786A1 (en) * 2009-03-30 2010-10-14 Mount Sinai School Of Medicine Of New York University Influenza virus vaccines and uses thereof
JP2013520167A (ja) * 2010-02-18 2013-06-06 テクノヴァックス,インコーポレイテッド 万能ウイルス様粒子(vlp)インフルエンザワクチン
KR102072582B1 (ko) * 2012-12-31 2020-02-03 엘지전자 주식회사 듀얼 디스플레이 방법 및 장치

Similar Documents

Publication Publication Date Title
JP2013520167A5 (enExample)
JP2013014622A5 (enExample)
WO2011103453A3 (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease
JP2017509667A5 (enExample)
JP2012143233A5 (enExample)
JP2015525757A5 (enExample)
JP2012107057A5 (enExample)
JP2016535100A5 (enExample)
JP2019516735A5 (enExample)
JP2015533163A5 (enExample)
JP2015501646A5 (enExample)
JP2015518492A5 (enExample)
JP2013083044A5 (enExample)
JP2016500312A5 (enExample)
JP2016540026A5 (enExample)
JP2015511646A5 (enExample)
JP2012516348A5 (enExample)
JP2014507563A5 (enExample)
JP2014529579A5 (enExample)
JP2015030781A5 (enExample)
CL2013002325A1 (es) Compuestos derivados de 4-amino-2-butenamidas, inhibidores de catepsina c; composicion farmaceutica que los comprende; procedimiento de preparacion de la composicion farmaceutica; uso del compuesto en el tratamiento de enfermedad pulmonar obstructiva cronica.
JP2017014205A5 (enExample)
WO2016020408A3 (en) Compounds for preventing ototoxicity
JP2017516883A5 (enExample)
HK1179177A (en) Vaccines for use in the prophylaxis and treatment of influenza virus disease